Cancer cells that migrate into bloodstream are called
circulating tumor cells or CTCs. In 2007, a team led by biochemical engineer
Mehmet Toner of Massachussets General Hospital in Boston devised a method to
trap and detect CTCs on a silicon chip the size of a microscope slide etched
with micro channels each no wider than a hair. Toner pumped samples of whole
blood through the channels, which were coated with an antibody designed to trap
any cancer cell that carries a common surface protein, much as flypaper snags
pesky insects. But cancer cells without that protein, such as melanoma slid
past undetected.
The new device gets around that limitation. Called the
CTC-iChip system (the "i" is for "inertial focusing"), it
targets blood cells instead of cancer cells. Sorting by cell size, the first
chip skims off small red blood cells and platelets, letting only CTCs and white
blood cells flow past. Then, a second chip winds the cells through curving
channels, channeling the remaining cells into a single-file line. Magnetic
beads the size of a bacterium attach to specific surface proteins on white
blood cells, and a magnetic field nudges these cells out of the stream of CTCs.
That leaves just the CTCs, which can be collected in a vial and individually
analyzed by conventional lab methods.
0 comments:
Post a Comment